Combined carriership of TLR9 -1237C and CD14 -260T alleles enhances the risk of developing chronic relapsing pouchitis

Table 2 Clinical data obtained from IPAA patients

IPAA patients	Mean (SD)	Median	Range
Age (yr) at diagnosis of ulcerative colitis	29.7 (11.7)	27	8-61
Time (yr) from diagnosis of ulcerative colitis to IPAA surgery	6.3 (5.5)	5	0-34
Time from IPAA surgery to first episode of pouchitis
Total pouchitis group (n = 78)	2.8 (3.1)	2	0-12
Infrequent pouchitis ( ≤2 episodes, n = 43)	3.7 (3.3)	3	0-12
Chronic relapsing pouchitis (≥3 episodes, n = 35)	2 (2.6)	1	0-12
Pattern of pouchitis
Duration of pouch (yr)
No episodes of pouchitis (n = 79)	6.3 (4.1)	5	0-14
Infrequent pouchitis ( ≤2 episodes, n = 43)	7.6 (3.8)	7	1-16
Chronic relapsing pouchitis (≥3 episodes, n = 35)	7.9 (3.6)	7	2–14